Navigation Links
Mutant sperm beat out healthy brethren in study

According to Researchers Men produce more mutant sperm as they get older //and they found to their surprise that some of these mutations give the sperm an edge.

The deformed sperm increase the risk of disease in the men's offspring, but nonetheless are likely to beat out their healthy counterparts in the race to fertilize the egg, the researchers said.
The research team was trying to explain why a rare genetic disease called Apert syndrome is more common in children born to older fathers. Apert syndrome is marked by webbed fingers and early fusion of the skull bones, which must be surgically corrected.

Researchers were looking for two mutations that cause virtually all cases of Apert syndrome. "For some reason, a sperm with one of these mutations is more likely to be used to make a baby than normal sperm," said researchers.

The researchers studied sperm from 148 men aged 21 to 80. Most of the men did not have children with Apert syndrome but 15 of the men did. The two mutations that cause most cases of Apert syndrome affect a gene and the protein it controls called fibroblast growth-factor receptor-2. Men over 60 were three times as likely as men under 30 to have sperm with at least one of these changes. The mutations were found only in sperm -- which men make freshly daily -- and not in the blood.

In men with Apert children, the younger men were more likely to have the mutation than the older men.

"Men over age 52 are six times more likely than a 27-year-old to have a child with Apert syndrome, so the mutation rate alone can't account for the condition's link to paternal age" said Researchers.

Literally hundreds of millions of sperm are made in each batch, so in most cases there are still many normal sperm available. Because the few mutated sperm are more likely to be used to make a baby than would be expected, the mutation must provide them some competitive advantage over their normal counterparts.
'"/>




Page: 1

Related medicine news :

1. Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants
2. New Drugs To Combat Mutant Bugs
3. Gene Transfer Using Mutant Form of Good Cholesterol Cuts Vascular Plaque and Inflammation
4. Chronic Kidney Disease Related To Mutant Gene
5. Shapely sperm-a valuable indicator of fertility
6. Stem cells grown into sperm cells
7. Limiting sperm motility for contraception
8. Gay men cannot donate sperm
9. SEMEN – More than just a sperm carrie
10. Shortage of donors at sperm bank clinics
11. For healthy lungs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is an ... that it meets its goals and delivers value to the wool industry., The RWS ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 - ... on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in ... will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: